IP Library Assignment 014122/0642
Patent Assignment
Reel/Frame 014122/0642

Assignment of Assignor's Interest

Recorded: 2003-06-04 Pages: 5
Assignors
DOLLE, ROLAND ELLWOOD
Executed: 2003-04-28
LEBOURDONNEC, BERTRAND
Executed: 2003-04-28
Assignee
ADOLOR CORPORATION
620 PENNSYLVANIA DRIVE, EXTON, PENNSYLVANIA, 19341-1127
Covered Property (1)
Substituted Piperidine Compounds
Patent: 7,381,721 →
Application: 10/390,522 →
Publication: US 2004/0186135
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Re-Record to Correct the Name of the Second Assignor, Previously Recorded on Reel 014122 Frame 0642. Jun 24, 2004
From: DOLLE, ROLAND ELLWOOD; LE BOURDONNEC, BERNAND
To: ADOLOR CORPORATION
Reel/Frame 014772/0245 →
Corrective Assignment to Correct the 1) 2ND Inventor Name Previously Recorded on Reel 014772 Frame 0245. Assignor(S) Hereby Confirms the Above Correction. Feb 15, 2007
From: DOLLE, ROLAND E.; LE BOURDONNEC, BERTRAND
To: ADOLOR CORPORATION
Reel/Frame 018901/0211 →
Security Agreement Nov 20, 2012
From: CUBIST PHARMACEUTICALS, INC.; ADOLOR CORPORATION; CALIXA THERAPEUTICS, INC.; CUBIST PHARMACEUTICALS HOLDINGS, INC.
To: ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT
Reel/Frame 029339/0669 →
Release of Security Interest Jul 24, 2015
From: ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT
To: CALIXA THERAPEUTICS, INC.; ADOLOR CORPORATION; CUBIST PHARMACEUTICALS, INC.
Reel/Frame 036180/0070 →